Australian scientists grow coronavirus in the lab — game-changing tool to diagnose, develop vaccines

Chinese released genome sequence of the virus to help in diagnosis but the real virus help verify all test methods.

Press Trust of India January 29, 2020 09:00:23 IST
Australian scientists grow coronavirus in the lab — game-changing tool to diagnose, develop vaccines

For the first time, the novel coronavirus has been grown from a cell culture outside China, a "significant breakthrough" that may help combat the deadly virus which has claimed over 130 lives and infected thousands, Australian scientists said on Wednesday.

The researchers from the University of Melbourne and the Royal Melbourne Hospital said the advance will allow accurate investigation and diagnosis of the virus globally.

"Chinese officials released the genome sequence of this novel coronavirus , which is helpful for diagnosis, however, having the real virus means we now have the ability to actually validate and verify all test methods, and compare their sensitivities and specificities — it will be a game-changer for diagnosis," said Julian Druce from The Royal Melbourne Hospital.

"The virus will be used as positive control material for the Australian network of public health laboratories, and also shipped to expert laboratories working closely with the World Health Organization (WHO) in Europe," Druce said.

Australian scientists grow <span class=coronavirus in the lab gamechanging tool to diagnose develop vaccines" width="1280" height="720" />

Having the actual virus will help test the methods of diagnosis and treatment.

Doherty Institute Deputy Director Mike Catton said the possession of a virus isolates extended what could be achieved with molecular technology in the fight against this virus.

The deadly coronavirus has claimed 132 lives and nearly 6,000 infection cases have been reported in China.

The grown virus is expected to be used to generate an antibody test, which allows detection of the virus in patients who haven't displayed symptoms and were therefore unaware they had the virus, the researchers said.

"An antibody test will enable us to retrospectively test suspected patients so we can gather a more accurate picture of how widespread the virus is, and consequently, among other things, the true mortality rate," Catton said.

"It will also assist in the assessment of effectiveness of trial vaccines," he said.

The virus was grown from a patient sample that arrived at the Royal Melbourne Hospital's Victorian Infectious Diseases Reference Laboratory (VIDRL) at the Doherty Institute on 24 January.

"We've planned for an incident like this for many, many years and that's really why we were able to get an answer so quickly," Catton said.

Updated Date:

also read

Coronavirus News Updates: Centre revises vaccine prices; Covishield to cost Rs 780 per dose, Covaxin Rs 1,410, Sputnik V Rs 1,145
India

Coronavirus News Updates: Centre revises vaccine prices; Covishield to cost Rs 780 per dose, Covaxin Rs 1,410, Sputnik V Rs 1,145

Coronavirus News Updates: The new prices include a 5 percent GST and the revised service charge of Rs 150 that private hospitals are allowed to charge per dose

Coronavirus News Updates: Maharashtra's COVID-19 tally increases by 9,798, toll by 198; Mumbai adds 758 new cases
India

Coronavirus News Updates: Maharashtra's COVID-19 tally increases by 9,798, toll by 198; Mumbai adds 758 new cases

Coronavirus News Updates: Of the new fatalities, 133 occurred in the last 48 hours while 65 took place in the last week. Another 450 deaths which had taken place earlier were added after reconciliation of records. The toll went up by 648

COVID-19 origins: Should we pay more attention to the lab leak theory and formally investigate it?
World

COVID-19 origins: Should we pay more attention to the lab leak theory and formally investigate it?

Whether the origin is zoonotic or not, it's necessary to question the consequences of our interactions with ecosystems.